ID   PT-KM-045
AC   CVCL_E1NX
SY   PT-KM-045-stb-CL
RX   PubMed=38915394;
CC   Population: African.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ear, skin, dermis; Note=From a keloid; UBERON=UBERON_0001459+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=38915394
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D18S51: 15,19
ST   D19S433: 13,18
ST   D21S11: 31,35
ST   D2S1338: 20,25
ST   D3S1358: 14,15
ST   D5S818: 8,11
ST   D7S820: 8,9
ST   D8S1179: 13,15
ST   FGA: 22,25
ST   Penta D: 9,10
ST   Penta E: 5,13
ST   TH01: 7,9
ST   TPOX: 8,9,10
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E1NY ! PT-KP-045
OI   CVCL_E1NZ ! PT-KT-045
SX   Female
AG   31Y
CA   Telomerase immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
RX   PubMed=38915394; DOI=10.3389/fimmu.2024.1326728; PMCID=PMC11194733;
RA   Sadiq A., Khumalo N.P., Bayat A.;
RT   "Development and validation of novel keloid-derived immortalized
RT   fibroblast cell lines.";
RL   Front. Immunol. 15:1326728.1-1326728.16(2024).
//